Genomic and transcriptional analyses of relapsed cross‐resistant SCLC PDX models revealed recurrent MYC paralog amplifications on ecDNA on relapsed cross‐resistant SCLC PDX models, highlighting their utility in studying treatment responses. The gene discussed is MYC; the disease is small cell lung carcinoma.